309 related articles for article (PubMed ID: 33248395)
21. Medical and surgical management of advanced Parkinson's disease.
Antonini A; Moro E; Godeiro C; Reichmann H
Mov Disord; 2018 Jul; 33(6):900-908. PubMed ID: 29570862
[TBL] [Abstract][Full Text] [Related]
22. Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
Catalan MJ; Molina-Arjona JA; Mir P; Cubo E; Arbelo JM; Martinez-Martin P;
J Neurol; 2018 Jun; 265(6):1279-1287. PubMed ID: 29557989
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and burden of dysautonomia in advanced Parkinson's disease.
Merola A; Romagnolo A; Comi C; Rosso M; Artusi CA; Zibetti M; Lanotte M; Duker AP; Maule S; Lopiano L; Espay AJ
Mov Disord; 2017 May; 32(5):796-797. PubMed ID: 28256092
[No Abstract] [Full Text] [Related]
24. On demand therapy for Parkinson's disease patients: Opportunities and choices.
Hauser RA; LeWitt PA; Comella CL
Postgrad Med; 2021 Sep; 133(7):721-727. PubMed ID: 34082655
[TBL] [Abstract][Full Text] [Related]
25. Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease.
Nyholm D; Klangemo K; Johansson A
Eur J Neurol; 2012 Aug; 19(8):1079-85. PubMed ID: 22360705
[TBL] [Abstract][Full Text] [Related]
26. [Continuous dopaminergic stimulation in Parkinson disease: possibilities in 2013].
Aschermann Z; Kovács N; Komoly S
Ideggyogy Sz; 2013 May; 66(5-6):209-10. PubMed ID: 23909024
[No Abstract] [Full Text] [Related]
27. Management of motor and non-motor symptoms in Parkinson's disease.
Sprenger F; Poewe W
CNS Drugs; 2013 Apr; 27(4):259-72. PubMed ID: 23515972
[TBL] [Abstract][Full Text] [Related]
28. [Medical and surgical treatment of Parkinson's disease].
Defebvre L; Moreau C
Presse Med; 2017 Mar; 46(2 Pt 1):218-224. PubMed ID: 28279509
[TBL] [Abstract][Full Text] [Related]
29. Drugs for Parkinson's disease.
Med Lett Drugs Ther; 2021 Feb; 63(1618):25-32. PubMed ID: 33647001
[No Abstract] [Full Text] [Related]
30. [Pharmacological treatments of Parkinson's disease].
Nomoto M; Iwata S; Kaseda S
Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):111-22. PubMed ID: 11233302
[TBL] [Abstract][Full Text] [Related]
31. Deep Brain Stimulation as a Rescue When Duodenal Levodopa Infusion Fails.
Nathoo N; Sankar T; Suchowersky O; Ba F
Can J Neurol Sci; 2019 Jan; 46(1):130-131. PubMed ID: 30688202
[No Abstract] [Full Text] [Related]
32. [Device-aided therapies in advanced Parkinson's disease].
Timofeeva AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):54-60. PubMed ID: 28139627
[TBL] [Abstract][Full Text] [Related]
33. Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review.
Volkmann J; Albanese A; Antonini A; Chaudhuri KR; Clarke CE; de Bie RM; Deuschl G; Eggert K; Houeto JL; Kulisevsky J; Nyholm D; Odin P; Østergaard K; Poewe W; Pollak P; Rabey JM; Rascol O; Ruzicka E; Samuel M; Speelman H; Sydow O; Valldeoriola F; van der Linden C; Oertel W
J Neurol; 2013 Nov; 260(11):2701-14. PubMed ID: 23287972
[TBL] [Abstract][Full Text] [Related]
34. Available and emerging treatments for Parkinson's disease: a review.
Hickey P; Stacy M
Drug Des Devel Ther; 2011; 5():241-54. PubMed ID: 21607020
[TBL] [Abstract][Full Text] [Related]
35. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
Deleu D; Hanssens Y; Northway MG
Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576
[TBL] [Abstract][Full Text] [Related]
36. Comparison chart: Drugs for Parkinson's disease.
Med Lett Drugs Ther; 2020 Dec; 62(1613):e1-e9. PubMed ID: 33647002
[No Abstract] [Full Text] [Related]
37. Enteral feeding in Parkinson's patients receiving levodopa/carbidopa intestinal gel.
Bove F; Bentivoglio AR; Naranian T; Fasano A
Parkinsonism Relat Disord; 2017 Sep; 42():109-111. PubMed ID: 28676196
[No Abstract] [Full Text] [Related]
38. [Current treatment strategies for Parkinson's disease].
Südmeyer M; Wojtecki L; Schnitzler A
Fortschr Neurol Psychiatr; 2011 Dec; 79(12):733-43. PubMed ID: 22161168
[No Abstract] [Full Text] [Related]
39. Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study.
Blaise AS; Baille G; Carrière N; Devos D; Dujardin K; Grolez G; Kreisler A; Kyheng M; Moreau C; Mutez E; Seguy D; Defebvre L
Rev Neurol (Paris); 2020 May; 176(4):268-276. PubMed ID: 31668287
[TBL] [Abstract][Full Text] [Related]
40. Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias.
Stocchi F; Nordera G; Marsden CD
Clin Neuropharmacol; 1997 Apr; 20(2):95-115. PubMed ID: 9099462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
